Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Change in Cash (2023 - 2025)

Bioharvest Sciences has reported Change in Cash over the past 3 years, most recently at $12.0 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 369.28% year-over-year to $12.0 million; the TTM value through Dec 2025 reached $20.6 million, up 60676.47%, while the annual FY2025 figure was $20.6 million, 60676.47% up from the prior year.
  • Change in Cash was $12.0 million for Q4 2025 at Bioharvest Sciences, up from $7.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $12.0 million in Q4 2025 and bottomed at -$2.4 million in Q3 2024.
  • The 3-year median for Change in Cash is $1.4 million (2024), against an average of $2.4 million.
  • Year-over-year, Change in Cash crashed 2271.29% in 2024 and then skyrocketed 401.46% in 2025.
  • Over 3 years, Change in Cash stood at $3.6 million in 2023, then decreased by 28.3% to $2.6 million in 2024, then skyrocketed by 369.28% to $12.0 million in 2025.
  • The last three reported values for Change in Cash were $12.0 million (Q4 2025), $7.2 million (Q3 2025), and $338000.0 (Q2 2025) per Business Quant data.